nodes	percent_of_prediction	percent_of_DWPC	metapath
Floxuridine—Skin toxicity—Bleomycin—melanoma	0.0475	0.0859	CcSEcCtD
Floxuridine—Nail changes—Bleomycin—melanoma	0.0377	0.0682	CcSEcCtD
Floxuridine—Onychomadesis—Docetaxel—melanoma	0.0369	0.0666	CcSEcCtD
Floxuridine—Skin toxicity—Docetaxel—melanoma	0.0267	0.0482	CcSEcCtD
Floxuridine—Nail changes—Docetaxel—melanoma	0.0212	0.0383	CcSEcCtD
Floxuridine—TYMS—Paclitaxel—Docetaxel—melanoma	0.0159	1	CbGdCrCtD
Floxuridine—TYMP—endothelium—melanoma	0.0115	0.257	CbGeAlD
Floxuridine—TYMP—blood vessel—melanoma	0.0106	0.237	CbGeAlD
Floxuridine—Enteritis—Docetaxel—melanoma	0.00899	0.0163	CcSEcCtD
Floxuridine—Zidovudine—TERT—melanoma	0.0089	0.817	CrCbGaD
Floxuridine—Nail disorder—Bleomycin—melanoma	0.00844	0.0153	CcSEcCtD
Floxuridine—Rash maculo-papular—Vemurafenib—melanoma	0.00822	0.0148	CcSEcCtD
Floxuridine—Photosensitivity—Vemurafenib—melanoma	0.00747	0.0135	CcSEcCtD
Floxuridine—Embolism—Temozolomide—melanoma	0.0072	0.013	CcSEcCtD
Floxuridine—Duodenal ulcer—Docetaxel—melanoma	0.00636	0.0115	CcSEcCtD
Floxuridine—Abscess—Carmustine—melanoma	0.00604	0.0109	CcSEcCtD
Floxuridine—Dry skin—Vemurafenib—melanoma	0.00601	0.0109	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—CDK4—melanoma	0.00575	0.0153	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—TRRAP—melanoma	0.00555	0.0148	CbGpPWpGaD
Floxuridine—TYMS—G1/S-Specific Transcription—PCNA—melanoma	0.0055	0.0147	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—EGF—melanoma	0.00535	0.0143	CbGpPWpGaD
Floxuridine—Lacrimation—Docetaxel—melanoma	0.00522	0.00944	CcSEcCtD
Floxuridine—Photosensitivity reaction—Vemurafenib—melanoma	0.00518	0.00935	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—BRAF—melanoma	0.00508	0.0136	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—RB1—melanoma	0.005	0.0133	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—CDH1—melanoma	0.00498	0.0133	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—MAP2K1—melanoma	0.00479	0.0128	CbGpPWpGaD
Floxuridine—Embolism—Docetaxel—melanoma	0.00479	0.00865	CcSEcCtD
Floxuridine—Nail disorder—Docetaxel—melanoma	0.00474	0.00856	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—RAI1—melanoma	0.00457	0.0122	CbGpPWpGaD
Floxuridine—TYMP—mammalian vulva—melanoma	0.0045	0.1	CbGeAlD
Floxuridine—TYMS—Fluoropyrimidine Activity—SMUG1—melanoma	0.00448	0.0119	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—TP73—melanoma	0.00447	0.0119	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—MCL1—melanoma	0.00447	0.0119	CbGpPWpGaD
Floxuridine—Disorientation—Bleomycin—melanoma	0.00444	0.00803	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—CDKN2A—melanoma	0.00439	0.0117	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—MDM2—melanoma	0.00426	0.0114	CbGpPWpGaD
Floxuridine—TYMS—skin of body—melanoma	0.00423	0.0941	CbGeAlD
Floxuridine—TYMP—Bladder Cancer—ERBB2—melanoma	0.0042	0.0112	CbGpPWpGaD
Floxuridine—TYMS—G1/S Transition—PKMYT1—melanoma	0.00415	0.0111	CbGpPWpGaD
Floxuridine—Alopecia—Vemurafenib—melanoma	0.00401	0.00725	CcSEcCtD
Floxuridine—Thrombophlebitis—Carmustine—melanoma	0.00401	0.00724	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—CXCL8—melanoma	0.00398	0.0106	CbGpPWpGaD
Floxuridine—Erythema—Vemurafenib—melanoma	0.00395	0.00714	CcSEcCtD
Floxuridine—Thrombophlebitis—Temozolomide—melanoma	0.00387	0.007	CcSEcCtD
Floxuridine—TYMS—mammalian vulva—melanoma	0.00386	0.0858	CbGeAlD
Floxuridine—Myocardial ischaemia—Docetaxel—melanoma	0.00382	0.00691	CcSEcCtD
Floxuridine—Lethargy—Dactinomycin—melanoma	0.00378	0.00684	CcSEcCtD
Floxuridine—Gastroenteritis—Temozolomide—melanoma	0.00378	0.00684	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—CCND1—melanoma	0.00371	0.0099	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—CDKN1A—melanoma	0.00359	0.00957	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—APAF1—melanoma	0.00358	0.00953	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—PKMYT1—melanoma	0.0035	0.00932	CbGpPWpGaD
Floxuridine—TYMS—E2F mediated regulation of DNA replication—E2F1—melanoma	0.00343	0.00915	CbGpPWpGaD
Floxuridine—Lacrimation increased—Docetaxel—melanoma	0.00333	0.00602	CcSEcCtD
Floxuridine—TYMS—Fluoropyrimidine Activity—ERCC2—melanoma	0.00333	0.00889	CbGpPWpGaD
Floxuridine—Pancytopenia—Bleomycin—melanoma	0.00326	0.0059	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—VEGFA—melanoma	0.00324	0.00863	CbGpPWpGaD
Floxuridine—TYMS—E2F mediated regulation of DNA replication—PCNA—melanoma	0.00323	0.00863	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Vemurafenib—melanoma	0.00322	0.00583	CcSEcCtD
Floxuridine—TYMP—head—melanoma	0.00322	0.0716	CbGeAlD
Floxuridine—Infection—Vemurafenib—melanoma	0.0032	0.00579	CcSEcCtD
Floxuridine—Nervous system disorder—Vemurafenib—melanoma	0.00316	0.00572	CcSEcCtD
Floxuridine—Dry skin—Temozolomide—melanoma	0.00307	0.00555	CcSEcCtD
Floxuridine—Pancytopenia—Dactinomycin—melanoma	0.00304	0.0055	CcSEcCtD
Floxuridine—Stomatitis—Bleomycin—melanoma	0.00299	0.0054	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—MYC—melanoma	0.00298	0.00794	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—MAPK1—melanoma	0.00291	0.00777	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—EGFR—melanoma	0.00291	0.00776	CbGpPWpGaD
Floxuridine—Pancytopenia—Carmustine—melanoma	0.00285	0.00515	CcSEcCtD
Floxuridine—Decreased appetite—Vemurafenib—melanoma	0.0028	0.00507	CcSEcCtD
Floxuridine—Stomatitis—Dactinomycin—melanoma	0.00278	0.00503	CcSEcCtD
Floxuridine—Haemoglobin—Bleomycin—melanoma	0.00276	0.005	CcSEcCtD
Floxuridine—TYMS—head—melanoma	0.00276	0.0614	CbGeAlD
Floxuridine—Pancytopenia—Temozolomide—melanoma	0.00275	0.00497	CcSEcCtD
Floxuridine—Haemorrhage—Bleomycin—melanoma	0.00275	0.00497	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—ARNT—melanoma	0.00272	0.00725	CbGpPWpGaD
Floxuridine—Agranulocytosis—Dactinomycin—melanoma	0.00267	0.00482	CcSEcCtD
Floxuridine—Photosensitivity reaction—Temozolomide—melanoma	0.00265	0.00478	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—PAX4—melanoma	0.00262	0.007	CbGpPWpGaD
Floxuridine—Stomatitis—Carmustine—melanoma	0.00261	0.00471	CcSEcCtD
Floxuridine—Thrombophlebitis—Docetaxel—melanoma	0.00258	0.00466	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CAPN1—melanoma	0.00257	0.00685	CbGpPWpGaD
Floxuridine—Body temperature increased—Vemurafenib—melanoma	0.00255	0.00461	CcSEcCtD
Floxuridine—Pharyngitis—Dactinomycin—melanoma	0.00255	0.0046	CcSEcCtD
Floxuridine—Stomatitis—Temozolomide—melanoma	0.00252	0.00455	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—SKP2—melanoma	0.0025	0.00668	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—TP53—melanoma	0.00244	0.00652	CbGpPWpGaD
Floxuridine—TYMS—E2F mediated regulation of DNA replication—RB1—melanoma	0.00243	0.00648	CbGpPWpGaD
Floxuridine—Alopecia—Bleomycin—melanoma	0.00243	0.00439	CcSEcCtD
Floxuridine—Haemoglobin—Carmustine—melanoma	0.00241	0.00436	CcSEcCtD
Floxuridine—Haemorrhage—Carmustine—melanoma	0.0024	0.00434	CcSEcCtD
Floxuridine—Erythema—Bleomycin—melanoma	0.00239	0.00433	CcSEcCtD
Floxuridine—Hypersensitivity—Vemurafenib—melanoma	0.00238	0.00429	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—HRAS—melanoma	0.00234	0.00623	CbGpPWpGaD
Floxuridine—Haemoglobin—Temozolomide—melanoma	0.00233	0.00421	CcSEcCtD
Floxuridine—TYMP—Fluoropyrimidine Activity—TP53—melanoma	0.00233	0.0062	CbGpPWpGaD
Floxuridine—Haemorrhage—Temozolomide—melanoma	0.00232	0.00419	CcSEcCtD
Floxuridine—Asthenia—Vemurafenib—melanoma	0.00231	0.00418	CcSEcCtD
Floxuridine—Pharyngitis—Temozolomide—melanoma	0.0023	0.00416	CcSEcCtD
Floxuridine—Lethargy—Docetaxel—melanoma	0.00228	0.00411	CcSEcCtD
Floxuridine—Alopecia—Dactinomycin—melanoma	0.00227	0.0041	CcSEcCtD
Floxuridine—TYMP—lymph node—melanoma	0.00225	0.0501	CbGeAlD
Floxuridine—Erythema—Dactinomycin—melanoma	0.00223	0.00403	CcSEcCtD
Floxuridine—Ill-defined disorder—Bleomycin—melanoma	0.00222	0.00401	CcSEcCtD
Floxuridine—Anaemia—Bleomycin—melanoma	0.00221	0.004	CcSEcCtD
Floxuridine—Diarrhoea—Vemurafenib—melanoma	0.00221	0.00399	CcSEcCtD
Floxuridine—Malaise—Bleomycin—melanoma	0.00216	0.0039	CcSEcCtD
Floxuridine—Leukopenia—Bleomycin—melanoma	0.00214	0.00387	CcSEcCtD
Floxuridine—Alopecia—Carmustine—melanoma	0.00212	0.00383	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—SKP2—melanoma	0.00209	0.00558	CbGpPWpGaD
Floxuridine—Erythema—Carmustine—melanoma	0.00209	0.00378	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	0.00207	0.00553	CbGpPWpGaD
Floxuridine—Ill-defined disorder—Dactinomycin—melanoma	0.00207	0.00374	CcSEcCtD
Floxuridine—Anaemia—Dactinomycin—melanoma	0.00206	0.00373	CcSEcCtD
Floxuridine—Vomiting—Vemurafenib—melanoma	0.00205	0.00371	CcSEcCtD
Floxuridine—Alopecia—Temozolomide—melanoma	0.00205	0.0037	CcSEcCtD
Floxuridine—Dry skin—Docetaxel—melanoma	0.00204	0.00369	CcSEcCtD
Floxuridine—Rash—Vemurafenib—melanoma	0.00203	0.00367	CcSEcCtD
Floxuridine—Dermatitis—Vemurafenib—melanoma	0.00203	0.00367	CcSEcCtD
Floxuridine—Headache—Vemurafenib—melanoma	0.00202	0.00365	CcSEcCtD
Floxuridine—Erythema—Temozolomide—melanoma	0.00202	0.00365	CcSEcCtD
Floxuridine—Discomfort—Bleomycin—melanoma	0.00201	0.00364	CcSEcCtD
Floxuridine—Malaise—Dactinomycin—melanoma	0.00201	0.00364	CcSEcCtD
Floxuridine—Cramp muscle—Docetaxel—melanoma	0.00201	0.00363	CcSEcCtD
Floxuridine—Leukopenia—Dactinomycin—melanoma	0.002	0.00361	CcSEcCtD
Floxuridine—Confusional state—Bleomycin—melanoma	0.00197	0.00356	CcSEcCtD
Floxuridine—Anaphylactic shock—Bleomycin—melanoma	0.00195	0.00353	CcSEcCtD
Floxuridine—Infection—Bleomycin—melanoma	0.00194	0.00351	CcSEcCtD
Floxuridine—TYMS—lymph node—melanoma	0.00193	0.043	CbGeAlD
Floxuridine—Anaemia—Carmustine—melanoma	0.00193	0.00349	CcSEcCtD
Floxuridine—Nausea—Vemurafenib—melanoma	0.00192	0.00346	CcSEcCtD
Floxuridine—Thrombocytopenia—Bleomycin—melanoma	0.00191	0.00346	CcSEcCtD
Floxuridine—Discomfort—Dactinomycin—melanoma	0.00188	0.00339	CcSEcCtD
Floxuridine—Angina pectoris—Docetaxel—melanoma	0.00188	0.00339	CcSEcCtD
Floxuridine—Ill-defined disorder—Temozolomide—melanoma	0.00187	0.00339	CcSEcCtD
Floxuridine—Leukopenia—Carmustine—melanoma	0.00187	0.00338	CcSEcCtD
Floxuridine—Anaemia—Temozolomide—melanoma	0.00187	0.00337	CcSEcCtD
Floxuridine—Anorexia—Bleomycin—melanoma	0.00186	0.00337	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	0.00185	0.00492	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	0.00185	0.00492	CbGpPWpGaD
Floxuridine—Pancytopenia—Docetaxel—melanoma	0.00183	0.00331	CcSEcCtD
Floxuridine—Malaise—Temozolomide—melanoma	0.00182	0.00329	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—E2F1—melanoma	0.00182	0.00485	CbGpPWpGaD
Floxuridine—Infection—Dactinomycin—melanoma	0.00181	0.00327	CcSEcCtD
Floxuridine—Leukopenia—Temozolomide—melanoma	0.00181	0.00327	CcSEcCtD
Floxuridine—Thrombocytopenia—Dactinomycin—melanoma	0.00178	0.00322	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—SKP2—melanoma	0.00176	0.0047	CbGpPWpGaD
Floxuridine—Anorexia—Dactinomycin—melanoma	0.00174	0.00314	CcSEcCtD
Floxuridine—Confusional state—Carmustine—melanoma	0.00172	0.00311	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—DCC—melanoma	0.00171	0.00455	CbGpPWpGaD
Floxuridine—Discomfort—Temozolomide—melanoma	0.0017	0.00307	CcSEcCtD
Floxuridine—Decreased appetite—Bleomycin—melanoma	0.0017	0.00307	CcSEcCtD
Floxuridine—Infection—Carmustine—melanoma	0.00169	0.00306	CcSEcCtD
Floxuridine—Stomatitis—Docetaxel—melanoma	0.00167	0.00303	CcSEcCtD
Floxuridine—Thrombocytopenia—Carmustine—melanoma	0.00167	0.00302	CcSEcCtD
Floxuridine—Confusional state—Temozolomide—melanoma	0.00166	0.003	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	0.00166	0.00442	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Temozolomide—melanoma	0.00165	0.00298	CcSEcCtD
Floxuridine—Infection—Temozolomide—melanoma	0.00164	0.00296	CcSEcCtD
Floxuridine—Anorexia—Carmustine—melanoma	0.00163	0.00294	CcSEcCtD
Floxuridine—Epistaxis—Docetaxel—melanoma	0.00162	0.00293	CcSEcCtD
Floxuridine—Nervous system disorder—Temozolomide—melanoma	0.00162	0.00292	CcSEcCtD
Floxuridine—Thrombocytopenia—Temozolomide—melanoma	0.00161	0.00292	CcSEcCtD
Floxuridine—Feeling abnormal—Bleomycin—melanoma	0.00161	0.00291	CcSEcCtD
Floxuridine—Agranulocytosis—Docetaxel—melanoma	0.0016	0.0029	CcSEcCtD
Floxuridine—Decreased appetite—Dactinomycin—melanoma	0.00158	0.00286	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—E2F1—melanoma	0.00158	0.00421	CbGpPWpGaD
Floxuridine—Anorexia—Temozolomide—melanoma	0.00157	0.00284	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—WT1—melanoma	0.00157	0.00419	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—CDK2—melanoma	0.00157	0.00418	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—REC8—melanoma	0.00156	0.00416	CbGpPWpGaD
Floxuridine—Haemoglobin—Docetaxel—melanoma	0.00155	0.0028	CcSEcCtD
Floxuridine—Body temperature increased—Bleomycin—melanoma	0.00154	0.00279	CcSEcCtD
Floxuridine—Haemorrhage—Docetaxel—melanoma	0.00154	0.00279	CcSEcCtD
Floxuridine—TYMP—Metabolism—ACER3—melanoma	0.00154	0.00411	CbGpPWpGaD
Floxuridine—Pharyngitis—Docetaxel—melanoma	0.00153	0.00277	CcSEcCtD
Floxuridine—Feeling abnormal—Dactinomycin—melanoma	0.0015	0.00271	CcSEcCtD
Floxuridine—Gastrointestinal pain—Dactinomycin—melanoma	0.00149	0.00269	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—PCNA—melanoma	0.00149	0.00397	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—ATM—melanoma	0.00149	0.00397	CbGpPWpGaD
Floxuridine—Decreased appetite—Carmustine—melanoma	0.00148	0.00268	CcSEcCtD
Floxuridine—Abdominal pain—Dactinomycin—melanoma	0.00144	0.0026	CcSEcCtD
Floxuridine—Body temperature increased—Dactinomycin—melanoma	0.00144	0.0026	CcSEcCtD
Floxuridine—Hypersensitivity—Bleomycin—melanoma	0.00144	0.0026	CcSEcCtD
Floxuridine—Decreased appetite—Temozolomide—melanoma	0.00143	0.00259	CcSEcCtD
Floxuridine—TYMP—Metabolism—UGT2B10—melanoma	0.00141	0.00376	CbGpPWpGaD
Floxuridine—Feeling abnormal—Carmustine—melanoma	0.00141	0.00254	CcSEcCtD
Floxuridine—Asthenia—Bleomycin—melanoma	0.0014	0.00253	CcSEcCtD
Floxuridine—Gastrointestinal pain—Carmustine—melanoma	0.00139	0.00252	CcSEcCtD
Floxuridine—Alopecia—Docetaxel—melanoma	0.00136	0.00246	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CDK2—melanoma	0.00136	0.00363	CbGpPWpGaD
Floxuridine—Feeling abnormal—Temozolomide—melanoma	0.00136	0.00245	CcSEcCtD
Floxuridine—Body temperature increased—Carmustine—melanoma	0.00135	0.00244	CcSEcCtD
Floxuridine—Abdominal pain—Carmustine—melanoma	0.00135	0.00244	CcSEcCtD
Floxuridine—Gastrointestinal pain—Temozolomide—melanoma	0.00135	0.00244	CcSEcCtD
Floxuridine—Erythema—Docetaxel—melanoma	0.00134	0.00243	CcSEcCtD
Floxuridine—Hypersensitivity—Dactinomycin—melanoma	0.00134	0.00243	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—E2F1—melanoma	0.00132	0.00352	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—HS3ST5—melanoma	0.00131	0.0035	CbGpPWpGaD
Floxuridine—Asthenia—Dactinomycin—melanoma	0.00131	0.00236	CcSEcCtD
Floxuridine—Abdominal pain—Temozolomide—melanoma	0.0013	0.00235	CcSEcCtD
Floxuridine—Body temperature increased—Temozolomide—melanoma	0.0013	0.00235	CcSEcCtD
Floxuridine—Muscle spasms—Docetaxel—melanoma	0.00129	0.00233	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—RB1—melanoma	0.00129	0.00344	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CDK4—melanoma	0.00129	0.00343	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—INCENP—melanoma	0.00128	0.00342	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—PKMYT1—melanoma	0.00128	0.00342	CbGpPWpGaD
Floxuridine—Hypersensitivity—Carmustine—melanoma	0.00126	0.00227	CcSEcCtD
Floxuridine—Diarrhoea—Dactinomycin—melanoma	0.00125	0.00225	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—PCNA—melanoma	0.00124	0.00332	CbGpPWpGaD
Floxuridine—Vomiting—Bleomycin—melanoma	0.00124	0.00225	CcSEcCtD
Floxuridine—Anaemia—Docetaxel—melanoma	0.00124	0.00224	CcSEcCtD
Floxuridine—Rash—Bleomycin—melanoma	0.00123	0.00223	CcSEcCtD
Floxuridine—Dermatitis—Bleomycin—melanoma	0.00123	0.00222	CcSEcCtD
Floxuridine—Asthenia—Carmustine—melanoma	0.00122	0.00221	CcSEcCtD
Floxuridine—Hypersensitivity—Temozolomide—melanoma	0.00121	0.00219	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN2B—melanoma	0.00121	0.00323	CbGpPWpGaD
Floxuridine—Leukopenia—Docetaxel—melanoma	0.0012	0.00217	CcSEcCtD
Floxuridine—TYMS—Fluoropyrimidine Activity—TP53—melanoma	0.00119	0.00317	CbGpPWpGaD
Floxuridine—Asthenia—Temozolomide—melanoma	0.00118	0.00214	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—GNA11—melanoma	0.00117	0.00313	CbGpPWpGaD
Floxuridine—Diarrhoea—Carmustine—melanoma	0.00117	0.00211	CcSEcCtD
Floxuridine—Nausea—Bleomycin—melanoma	0.00116	0.0021	CcSEcCtD
Floxuridine—Vomiting—Dactinomycin—melanoma	0.00116	0.00209	CcSEcCtD
Floxuridine—Rash—Dactinomycin—melanoma	0.00115	0.00208	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—INCENP—melanoma	0.00115	0.00306	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—PKMYT1—melanoma	0.00115	0.00306	CbGpPWpGaD
Floxuridine—TYMS—G1/S Transition—CDK2—melanoma	0.00114	0.00303	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—CDKN2A—melanoma	0.00113	0.00302	CbGpPWpGaD
Floxuridine—Diarrhoea—Temozolomide—melanoma	0.00113	0.00204	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—RB1—melanoma	0.00112	0.00299	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—E2F1—melanoma	0.00111	0.00296	CbGpPWpGaD
Floxuridine—Confusional state—Docetaxel—melanoma	0.00111	0.002	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—HDAC2—melanoma	0.0011	0.00294	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Docetaxel—melanoma	0.0011	0.00198	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—GNAQ—melanoma	0.00109	0.00291	CbGpPWpGaD
Floxuridine—Infection—Docetaxel—melanoma	0.00109	0.00197	CcSEcCtD
Floxuridine—Vomiting—Carmustine—melanoma	0.00108	0.00196	CcSEcCtD
Floxuridine—Nausea—Dactinomycin—melanoma	0.00108	0.00196	CcSEcCtD
Floxuridine—Rash—Carmustine—melanoma	0.00108	0.00194	CcSEcCtD
Floxuridine—Nervous system disorder—Docetaxel—melanoma	0.00107	0.00194	CcSEcCtD
Floxuridine—Dermatitis—Carmustine—melanoma	0.00107	0.00194	CcSEcCtD
Floxuridine—Thrombocytopenia—Docetaxel—melanoma	0.00107	0.00194	CcSEcCtD
Floxuridine—Headache—Carmustine—melanoma	0.00107	0.00193	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—PCNA—melanoma	0.00105	0.00279	CbGpPWpGaD
Floxuridine—Vomiting—Temozolomide—melanoma	0.00105	0.00189	CcSEcCtD
Floxuridine—Anorexia—Docetaxel—melanoma	0.00104	0.00189	CcSEcCtD
Floxuridine—Rash—Temozolomide—melanoma	0.00104	0.00188	CcSEcCtD
Floxuridine—Dermatitis—Temozolomide—melanoma	0.00104	0.00188	CcSEcCtD
Floxuridine—Headache—Temozolomide—melanoma	0.00103	0.00187	CcSEcCtD
Floxuridine—Zidovudine—ALB—melanoma	0.00102	0.0934	CrCbGaD
Floxuridine—Nausea—Carmustine—melanoma	0.00101	0.00183	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—NGFR—melanoma	0.00101	0.00268	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—CDKN1B—melanoma	0.001	0.00267	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PLCB4—melanoma	0.000994	0.00265	CbGpPWpGaD
Floxuridine—Nausea—Temozolomide—melanoma	0.000979	0.00177	CcSEcCtD
Floxuridine—Zidovudine—ABCB1—melanoma	0.00097	0.0891	CrCbGaD
Floxuridine—TYMS—Cell Cycle—POT1—melanoma	0.000965	0.00257	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDK2—melanoma	0.000959	0.00256	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—MDM2—melanoma	0.000955	0.00255	CbGpPWpGaD
Floxuridine—Decreased appetite—Docetaxel—melanoma	0.000953	0.00172	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—RB1—melanoma	0.000935	0.00249	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—SLC6A11—melanoma	0.000934	0.00249	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIP4K2A—melanoma	0.000934	0.00249	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—CDKN1A—melanoma	0.000926	0.00247	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.000917	0.00245	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—MTAP—melanoma	0.000909	0.00242	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDK4—melanoma	0.000906	0.00242	CbGpPWpGaD
Floxuridine—Feeling abnormal—Docetaxel—melanoma	0.000903	0.00163	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.000896	0.00239	CbGpPWpGaD
Floxuridine—Gastrointestinal pain—Docetaxel—melanoma	0.000896	0.00162	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—melanoma	0.000872	0.00232	CbGpPWpGaD
Floxuridine—Body temperature increased—Docetaxel—melanoma	0.000866	0.00157	CcSEcCtD
Floxuridine—Abdominal pain—Docetaxel—melanoma	0.000866	0.00157	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.00086	0.00229	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.000842	0.00225	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.000833	0.00222	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—melanoma	0.000831	0.00222	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.000825	0.0022	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—LUM—melanoma	0.00081	0.00216	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PHGDH—melanoma	0.00081	0.00216	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.000809	0.00216	CbGpPWpGaD
Floxuridine—Hypersensitivity—Docetaxel—melanoma	0.000807	0.00146	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—melanoma	0.000804	0.00214	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—HPSE—melanoma	0.000795	0.00212	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.000794	0.00212	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ACER3—melanoma	0.000789	0.0021	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—RB1—melanoma	0.000788	0.0021	CbGpPWpGaD
Floxuridine—Asthenia—Docetaxel—melanoma	0.000786	0.00142	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.00078	0.00208	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CUBN—melanoma	0.00078	0.00208	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—MYC—melanoma	0.000767	0.00205	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.000765	0.00204	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—SDHD—melanoma	0.000753	0.00201	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CSPG4—melanoma	0.000753	0.00201	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—BSG—melanoma	0.000753	0.00201	CbGpPWpGaD
Floxuridine—Diarrhoea—Docetaxel—melanoma	0.00075	0.00136	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—FAS—melanoma	0.000749	0.002	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GPAM—melanoma	0.00073	0.00195	CbGpPWpGaD
Floxuridine—TYMS—G1/S Transition—CDKN1B—melanoma	0.000728	0.00194	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.000726	0.00194	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—UGT2B10—melanoma	0.000722	0.00192	CbGpPWpGaD
Floxuridine—Vomiting—Docetaxel—melanoma	0.000697	0.00126	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN2A—melanoma	0.000692	0.00185	CbGpPWpGaD
Floxuridine—Rash—Docetaxel—melanoma	0.000691	0.00125	CcSEcCtD
Floxuridine—Dermatitis—Docetaxel—melanoma	0.00069	0.00125	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.000689	0.00184	CbGpPWpGaD
Floxuridine—Headache—Docetaxel—melanoma	0.000687	0.00124	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.000686	0.00183	CbGpPWpGaD
Floxuridine—TYMS—G1/S Transition—CDKN1A—melanoma	0.000672	0.00179	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—HS3ST5—melanoma	0.000671	0.00179	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—MYC—melanoma	0.000667	0.00178	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—CDK4—melanoma	0.000659	0.00176	CbGpPWpGaD
Floxuridine—Nausea—Docetaxel—melanoma	0.000651	0.00118	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—SKP2—melanoma	0.000646	0.00172	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.000646	0.00172	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—NOS2—melanoma	0.00064	0.00171	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.000639	0.0017	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PLA2G6—melanoma	0.00062	0.00165	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN1B—melanoma	0.000613	0.00164	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.000602	0.0016	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—PPARG—melanoma	0.000599	0.0016	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.000592	0.00158	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—AURKA—melanoma	0.000591	0.00158	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CCND1—melanoma	0.000585	0.00156	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MLH1—melanoma	0.000585	0.00156	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—SKP2—melanoma	0.000578	0.00154	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.000572	0.00152	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN1A—melanoma	0.000566	0.00151	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—VCAN—melanoma	0.000557	0.00149	CbGpPWpGaD
Floxuridine—TYMS—G1/S Transition—MYC—melanoma	0.000557	0.00148	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—TP53—melanoma	0.000548	0.00146	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.000544	0.00145	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—AURKA—melanoma	0.000529	0.00141	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.000516	0.00138	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—APEX1—melanoma	0.000513	0.00137	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.000509	0.00136	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PLCB4—melanoma	0.000508	0.00136	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000502	0.00134	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.000491	0.00131	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIP4K2A—melanoma	0.000478	0.00127	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SLC6A11—melanoma	0.000478	0.00127	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CYP17A1—melanoma	0.00047	0.00125	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—MYC—melanoma	0.000469	0.00125	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—MTAP—melanoma	0.000465	0.00124	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.000465	0.00124	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—APEX1—melanoma	0.000459	0.00122	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.000455	0.00121	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN2B—melanoma	0.000444	0.00118	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GNA11—melanoma	0.000444	0.00118	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000443	0.00118	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.000439	0.00117	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—FASN—melanoma	0.000434	0.00116	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.000429	0.00114	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000428	0.00114	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—SLC5A5—melanoma	0.000427	0.00114	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000426	0.00114	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PHGDH—melanoma	0.000414	0.00111	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—LUM—melanoma	0.000414	0.00111	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GNAQ—melanoma	0.000413	0.0011	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CD44—melanoma	0.000413	0.0011	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—PTEN—melanoma	0.000411	0.0011	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—E2F1—melanoma	0.000408	0.00109	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—HPSE—melanoma	0.000406	0.00108	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—PRKCA—melanoma	0.000399	0.00106	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CUBN—melanoma	0.000399	0.00106	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN2B—melanoma	0.000397	0.00106	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CYP1B1—melanoma	0.000396	0.00106	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000386	0.00103	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SDHD—melanoma	0.000385	0.00103	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—BSG—melanoma	0.000385	0.00103	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CSPG4—melanoma	0.000385	0.00103	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—PCNA—melanoma	0.000384	0.00103	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GPAM—melanoma	0.000373	0.000995	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000366	0.000975	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—E2F1—melanoma	0.000364	0.000972	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—PRKCA—melanoma	0.000357	0.000952	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000356	0.000948	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDK2—melanoma	0.000352	0.000938	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000348	0.000927	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000348	0.000927	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—PCNA—melanoma	0.000344	0.000917	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDK4—melanoma	0.000332	0.000886	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—TERT—melanoma	0.000332	0.000885	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000331	0.000883	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000329	0.000876	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ABCB1—melanoma	0.000326	0.000869	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PLA2G6—melanoma	0.000317	0.000846	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDK2—melanoma	0.000314	0.000838	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000302	0.000805	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PRKCA—melanoma	0.0003	0.0008	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—ATM—melanoma	0.000298	0.000796	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ERCC2—melanoma	0.000297	0.000793	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDK4—melanoma	0.000297	0.000792	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000292	0.000779	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—RB1—melanoma	0.000289	0.00077	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—VCAN—melanoma	0.000285	0.00076	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—TP53—melanoma	0.00028	0.000747	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—RB1—melanoma	0.000258	0.000689	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—IL6—melanoma	0.000257	0.000684	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN2A—melanoma	0.000254	0.000677	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000247	0.000657	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP17A1—melanoma	0.00024	0.000641	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CG—melanoma	0.000235	0.000626	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GNA11—melanoma	0.000227	0.000606	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN2A—melanoma	0.000227	0.000606	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PPARG—melanoma	0.000227	0.000605	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN1B—melanoma	0.000225	0.0006	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—FASN—melanoma	0.000222	0.000593	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MDM2—melanoma	0.00022	0.000587	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SLC5A5—melanoma	0.000219	0.000583	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CCND1—melanoma	0.000215	0.000572	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GNAQ—melanoma	0.000211	0.000563	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CD44—melanoma	0.000211	0.000563	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN1A—melanoma	0.000208	0.000554	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CD—melanoma	0.000206	0.000551	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ALB—melanoma	0.000204	0.000544	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP1B1—melanoma	0.000202	0.00054	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN1B—melanoma	0.000201	0.000536	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CCND1—melanoma	0.000192	0.000512	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN1A—melanoma	0.000186	0.000495	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CB—melanoma	0.00018	0.00048	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PTGS2—melanoma	0.000178	0.000476	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—MAPK3—melanoma	0.000177	0.000472	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—MYC—melanoma	0.000172	0.000459	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—MAPK1—melanoma	0.000168	0.000449	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ABCB1—melanoma	0.000167	0.000444	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MAPK3—melanoma	0.000158	0.000422	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PTEN—melanoma	0.000156	0.000415	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MYC—melanoma	0.000154	0.00041	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PRKCA—melanoma	0.000153	0.000409	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ERCC2—melanoma	0.000152	0.000406	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MAPK1—melanoma	0.000151	0.000401	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—TP53—melanoma	0.000126	0.000337	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CG—melanoma	0.00012	0.00032	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PPARG—melanoma	0.000116	0.000309	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CA—melanoma	0.00011	0.000293	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CD—melanoma	0.000106	0.000282	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ALB—melanoma	0.000104	0.000278	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CB—melanoma	9.21e-05	0.000246	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTGS2—melanoma	9.12e-05	0.000243	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—AKT1—melanoma	8.96e-05	0.000239	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTEN—melanoma	7.96e-05	0.000212	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CA—melanoma	5.61e-05	0.00015	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—AKT1—melanoma	4.59e-05	0.000122	CbGpPWpGaD
